Indevus Pharmaceuticals Inc., of Lexington, Mass., elected Cheryl Morley and Stephen McCluski to its board...Locus Pharmaceuticals Inc., of Blue Bell, Pa., appointed James Bergey vice president of business development and Frank Guarnieri principal founding scientist

BioMarker Pharmaceuticals Inc., of Campbell, Calif., appointed Paul Watkins to vice president of business development...City of Hope in Los Angeles named Michael Friedman president and CEO...Protein Polymer Technologies Inc., of San Diego, elected Phillip Berman and Edward Cape to its board

Biopure Corp., of Cambridge, Mass., named Ronald Richards chief financial officer and senior vice president of business development

Inc., of Bothell, Wash., appointed Jade Brown senior director, marketing and business development...National Institutes of Health division, the National Institute of Allergy and Infectious Diseases, added Anthony Alessandro, Charles Davis, Anne Munoz-Furlong, Raymond O'Brien and Anjana Rao to its National Advisory Allergy and Infectious Diseases Council

Gentris Corp., of Research Triangle Park, N.C., added Gary Pace as vice president for corporate development and legal affairs, and promoted David Gessner to vice president for business development and marketing and Scott Clark to executive director of laboratory services

Renovis Inc., of South San Francisco, added John Doyle as vice president of finance and chief financial officer, Jacob Huff as vice president of clinical development, Michael Kelly as senior director of chemistry, John Kollins as vice president of business development and Paula Serbin as vice president of human resources

AtheroGenics Inc., of Atlanta, elected David Bearman to its board and to serve on its audit committee...Oxford BioMedica plc, of Oxford, UK, appointed David Higgins vice president for business development at Oxford's San Diego subsidiary

Endovasc Ltd., of Montgomery, Texas, added Greg Creekmore as vice president for business development

XOMA Ltd., of Berkeley, Calif., appointed Michel Bergh vice president of business development

He will focus on biotechnology and medical device investments...North Carolina Biotechnology Center, of Research Triangle Park, N.C., named Paul Wood vice president of business and technology development...Novuspharma SpA, of Milan, Italy, appointed Karl Hanks manager of investor relations and corporate communications

GenOdyssee SA, of Paris, appointed Jean-Marc Giry vice president of strategic planning, Philippe Remes vice president of investor relations and David Briscoe vice president of business development

InvestBio, of New York, named Robert LeBoyer managing director and director of research...Spherics Inc., of Lincoln, R.I., appointed Mathias Woker vice president of business development, Mark Iampietro director of quality assurance and Daniel Magiera principal scientist in analytical chemistry

Cubist Pharmaceuticals Inc., of Lexington, Mass., hired Oliver Fetzer as senior vice president of business development and Robert Janosky as vice president of manufacturing

Antigenics Inc., of New York, appointed Deanna Petersen vice president of business development...Laurence McCarthy, former president and CEO, will become chairman and chief technology officer

Also, it elected Franz Cristiani, Elaine Heron and Vijay Samant to its board...Esperion Therapeutics Inc., of Ann Arbor, Mich., appointed William Brinkerhoff vice president of business development...NanoBio Corp., of Ann Arbor, Mich., appointed Herbert Amster and Kent Talcott to its board

ARC Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Michael Diamond and Victor Gomel to its scientific advisory board...Nobex Corp., of Research Triangle Park, N.C., appointed Jennifer Filbey vice president of business and market development

Ribozyme Pharmaceuticals Inc., of Boulder, Colo., appointed Barry Polisky vice president of research, and promoted Larry Kahn to vice president of business development and Bharat Chowrira to vice president, legal affairs, licensing and patent counsel

Amphora Discovery Corp., of Research Triangle Park, N.C., added Cesar Collado as vice president of business development and commercialization and Holly Marcum as executive director of business development and commercialization

and Lioudmila Tchistiakova as section head, microbiology and genomics...and named John Prunty treasurer and assistant corporate secretary...Third Wave Technologies Inc., of Madison, Wis., added Lori Lehman as vice president of business development for its genomics unit and David Nuti as corporate controller